RGLS - Regulus Therapeutics Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts3333
Avg. Estimate-0.25-0.25-1.04-1.08
Low Estimate-0.27-0.26-1.13-1.18
High Estimate-0.24-0.24-0.88-1.02
Year Ago EPS-1.18-0.98-5.59-1.04
Revenue EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts2233
Avg. Estimate10k10k6.81M3.39M
Low EstimateN/AN/A6.8M70k
High Estimate20k20k6.83M10M
Year Ago Sales18k18k72k6.81M
Sales Growth (year/est)-44.40%-44.40%9,358.30%-50.20%
Earnings History9/29/201812/30/20183/30/20196/29/2019
EPS Est.-1.25-0.92-1.15-0.54
EPS Actual-1.18-0.98-0.31-0.3
Difference0.07-0.060.840.24
Surprise %5.60%-6.50%73.00%44.40%
EPS TrendCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Current Estimate-0.25-0.25-1.04-1.08
7 Days Ago-0.5-0.49-1.86-1.98
30 Days Ago-0.54-0.52-1.92-2.1
60 Days Ago-0.54-0.52-1.92-1.69
90 Days Ago-0.54-0.52-1.92-1.69
EPS RevisionsCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Up Last 7 Days2221
Up Last 30 Days3332
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesRGLSIndustrySectorS&P 500
Current Qtr.78.80%N/AN/A-0.00
Next Qtr.74.50%N/AN/A0.08
Current Year81.40%N/AN/A0.03
Next Year-3.80%N/AN/A0.10
Next 5 Years (per annum)39.60%N/AN/A0.08
Past 5 Years (per annum)N/AN/AN/AN/A